Subject Index. Bariatric surgery, obesity management 134

Size: px
Start display at page:

Download "Subject Index. Bariatric surgery, obesity management 134"

Transcription

1 Subject Index Acromegaly, PCOS differential diagnosis 149, 150, 154, 155 Adipokines, see specific adipokines Adiponectin, metabolic syndrome role Adolescents, PCOS diagnosis 16, 17 Adrenal hyperplasia, see Congenital adrenal hyperplasia, Non-classic adrenal hyperplasia Advanced glycation end products, PCOS role 19 Aldosterone, cardiovascular disease risk in PCOS 69, 70 AMP-dependent protein kinase, metformin effects Androgen receptor, sensitivity in PCOS 35 Androgens, see Hyperandrogenism Anovulation anti-müllerian hormone in pathophysiology 26 etiology 36, 130 metformin benefits ovulation inducers aromatase inhibitors 135, 136 clomiphene citrate 134, 135 follicle-stimulating hormone 137 gonadotropin-releasing hormone analogs 137, 138 laparoscopic ovarian drilling 138 letrozole 135, 136 metformin 136, 137 tamoxifen 135 phenotypes in PCOS 9, 10 Anti-Müllerian hormone, anovulation pathophysiology 26 Aromatase, inhibitors for ovulation induction 135, 136 Atherosclerosis, see Cardiovascular disease Bariatric surgery, obesity management 134 Cardiovascular disease arterial stiffness 76, 77 dyslipidemia, see Dyslipidemia endothelial dysfunction epidemiology in PCOS 65, 66 metabolic syndrome, see Metabolic syndrome non-classic adrenal hyperplasia risk factors insulin resistance 166, 167 obesity 166 overview 165 oral contraceptives and risks general population PCOS oxidative stress, see Oxidative stress risk factors in PCOS aldosterone 69, 70 dyslipidemia 69 hypertension 68, 69 insulin resistance 67, 68 obstructive sleep apnea 70, 71 overview 66, 67 phenotypes in PCOS and risk differences risk modification in PCOS drospirenone 79 glucagon-like peptide-1 agonists 79, 80 lifestyle modification 77 metformin 78 thiazolidinediones 78, 79 subclinical disease evaluation electron-beam computed tomography 72, 77 flow-mediated dilation

2 intima-media thickness 72, 75, 76 magnetic resonance imaging 72 pulse wave velocity 72, 76 β-cell, dysfunction in PCOS candidate gene studies 33 etiology 32 Chemerin, metabolic syndrome role 41, 44 Cholesterol, see Dyslipidemia, PCOS Classification, see Phenotypes, PCOS Clomiphene citrate, ovulation induction 134, 135 Congenital adrenal hyperplasia forms 163, 164 genetics 163 Cushing syndrome, PCOS differential diagnosis 14, 15, 148, 149, 153, 154 CYP11A, variants in PCOS 33, 34 CYP19, variants in PCOS 37 CYP21 congenital adrenal hyperplasia defects 163 heterozygotic carriers in PCOS 164, 165 non-classic adrenal hyperplasia defects 160 Cytoproterone acetate, hirsutism management 111 Definitions, PCOS 2 4, 129 Diabetes differential diagnosis , 155 gestational diabetes 151 type 1 disease 151 type 2 disease 150, 151 Diagnosis, PCOS adolescents 16, 17 secondary causes of PCOS signs 129 Differential diagnosis, PCOS acromegaly 149, 150, 154, 155 adrenal and ovarian androgen-producing tumors , 160, 161 adrenal-ovarian steroidogenic defects 146, 147 Cushing syndrome 14, 15, 148, 149, 153, 154 glucocorticoid metabolism alterations 147, 148 resistance 147 hyperinsulinemia and insulin resistance hyperprolactinemia 149 medication side effects 152, 153 non-classic adrenal hyperplasia 14 16, 153, 161, 162 overview thyroid dysfunction 149 Drospirenone cardiovascular risk modification 79 hirsutism management 112 Dyslipidemia, PCOS cardiovascular disease risks 69 HDL-cholesterol 54, 55 LDL-cholesterol 53, 54 pathophysiology aging and body composition 52, 53 hyperandrogenism 53 insulin resistance 53 prevalence 52 therapeutic targeting 60, 61 total cholesterol 3, 54 triglycerides 55 Electron-beam computed tomography, atherosclerosis diagnosis 72, 77 Finasteride, hirsutism management 111 Flow-mediated dilation, atherosclerosis diagnosis 72 Flutamide, hirsutism management 112 Follicle-stimulating hormone local inhibition 25 secretion in PCOS 23 Follicle-stimulating hormone, ovulation induction therapy 137 Folliculogenesis, PCOS candidate gene studies 36 excessive early growth 24 follicle-stimulating hormone local inhibition 25 secretion 23 follicular arrest 24 FTO, variants in PCOS 31, 37 Genetics, PCOS candidate gene studies androgen receptor sensitivity 35 β-cell dysfunction 32, 33 folliculogenesis 36 hyperandrogenism 33, 34 obesity and insulin resistance 31, 32 genome-wide association studies 36, 37 limitations of studies etiology lack of knowledge 29 Subject Index 173

3 gene effect size 30 heterogeneity of disease 29 inheritance mode 30 retrospective diagnosis difficulty 29 sub-fertility in disease 30 Genome-wide association studies, PCOS 36, 37 Glucagon-like peptide-1, agonists for cardiovascular risk modification 79, 80 Gonadotropin-releasing hormone, analogs for ovulation induction 137, 138 Hirsutism, see also Hyperandrogenism clinical evaluation differential diagnosis , 145 etiology 104 laboratory evaluation 108, 109 non-classic adrenal hyperplasia 160 oral contraceptive benefits 122 pathophysiology 104, 105 phenotypes in PCOS 8, 9 treatment Hyperandrogenism, see also Hirsutism adipokine response 48 adrenal and ovarian androgen-producing tumors , 160, 161 candidate gene studies 34 cardiovascular disease risk in PCOS 68, 69 dyslipidemia pathophysiology 53 etiology 33 metformin benefits 89 oral contraceptive benefits 122 pathophysiology 23, 24 phenotypes in PCOS 6 8 Hyperprolactinemia, PCOS differential diagnosis 149 Infertility, see also Anovulation assisted reproduction 138 etiology in PCOS 130, 131 lifestyle interventions behavior modification 133 diet 132 exercise 132, 133 overview 131, 132 non-classic adrenal hyperplasia 167 obesity management bariatric surgery 134 pharmacotherapy 133, 134 ovulation inducers aromatase inhibitors 135, 136 clomiphene citrate 134, 135 follicle-stimulating hormone 137 gonadotropin-releasing hormone analogs 137, 138 laparoscopic ovarian drilling 138 letrozole 135, 136 metformin 136, 137 tamoxifen 135 Insulin receptor, variants in PCOS 32 Insulin resistance, see also Metabolic syndrome candidate gene studies 31, 32 cardiovascular disease risk in PCOS 67, 68 differential diagnosis , 155 dyslipidemia pathophysiology 53 etiology 31 hyperglycemia and oxidative stress 56, 57, 59 non-classic adrenal hyperplasia 166, 167 oral contraceptives and risks general population 121 PCOS 124, 125 sensitizers, see Metformin, Thiazolidinediones Intima-media thickness, atherosclerosis diagnosis 72, 75, 76 Laparoscopic ovarian drilling, infertility management 138 Leptin, metabolic syndrome role 41, 42 Letrozole, ovulation induction 135, 136 α-lipoic acid, dyslipidemia management 61 Lipodystrophy, PCOS differential diagnosis 152 Luteinizing hormone ectopic secretion 150 elevation in PCOS 23, 143 phenotype differences in PCOS 12 Magnetic resonance imaging, atherosclerosis diagnosis 72 Metabolic syndrome, see also Insulin resistance, Obesity adipokines androgen effects in PCOS 48 general population PCOS metabolic profile phenotypes in PCOS 12, 13 metformin benefits 89, Subject Index

4 Metformin cardiovascular risk modification 78 clinical benefits anovulation and pregnancy hirsutism 113 hyperandrogenism 89 metabolic syndrome 89, 90 obesity 89, 90 dose dependence 92, 93 mechanism of action overview 84, 85 ovulation induction 136, 137 pharmacokinetics response prediction 93, 94 side effects 90 thiazolidinedione comparison 98 N-Acetylcysteine, PCOS management 61 Nitric oxide endothelial dysfunction in PCOS 73, 74 PCOS production 57, 58 Non-classic adrenal hyperplasia adrenal androgens and PCOS 160, 161 cardiovascular disease risks insulin resistance 166, 167 obesity 166 overview 165 CYP21 defects 160 epidemiology 160 hirsutism 107, 108 infertility 167 PCOS differential diagnosis 14 16, 153, 161, 162 Nonalcoholic fatty liver disease, PCOS association 61 Obesity infertility association 131 insulin resistance 151, 152 management bariatric surgery 134 pharmacotherapy 133, 134 non-classic adrenal hyperplasia 166 PCOS candidate gene studies 31, 32 etiology 31 metformin benefits 89, 90 Obstructive sleep apnea, cardiovascular disease risk in PCOS 70, 71 Omentin, metabolic syndrome role 41, 44 Oral contraceptives administration 117 benefits in PCOS 121, 122 cardiovascular risks general population PCOS composition 116 contraindications 117 hirsutism management 110, 111 metabolic risks general population 121 PCOS 124, 125 Organic cation transporter-1 metformin response prediction 94 metformin as substrate 91 Oxidative stress cardiovascular risk 51, 52 consequences in PCOS endogenous defenses 58, 59 free radical sources in PCOS adipose tissue 56 enzymatic sources 57 fatty acid oxidation 56 hyperglycemia 56, 57 mitochondrial dysfunction 58 nitric oxide 57, 58 insulin resistance pathophysiology 59 overview 55, 56 therapeutic targeting 60, 61 Peroxisome proliferator-activated receptor-γ activators, see Thiazolidinediones variants in PCOS 32 Peroxynitrite, PCOS production 58 Phenotypes, PCOS cardiovascular risk differences life cycle differences 5 limitations in classification anovulation 9, 10 hirsutism 8, 9 hyperandrogenism 6 8 polycystic ovarian morphology 10, 11 luteinizing hormone differences 12 management specificity 17, 18 metabolic profile differences 12, 13 nutrition role 18, 19 overview 2, 3, 129, 130 prevalence 4, 5 Polycystic ovarian morphology, phenotypes in PCOS 10, 11 Subject Index 175

5 Prevalence, phenotypes of PCOS 4, 5 Prolactin, see Hyperprolactinemia Pulse wave velocity, atherosclerosis diagnosis 72, 76 Reactive oxygen species, see Oxidative stress Resistin, metabolic syndrome role 41, 43 Retinol-binding protein-4, metabolic syndrome role 41, 44, 45 Sibutramine, obesity management 134 Sleep apnea, see Obstructive sleep apnea Spironolactone, hirsutism management 112 Statins, dyslipidemia management 60, 61 Tamoxifen, ovulation induction 135 Thiazolidinediones benefits in PCOS 97, 98 cardiovascular risk modification 78, 79 mechanism of action metformin comparison 98 overview 84, 85, 95 severe insulin resistance management Thyroid dysfunction, PCOS differential diagnosis 149 Triglycerides, see Dyslipidemia, PCOS Vaspin, metabolic syndrome role 41, 43 Visfatin, metabolic syndrome role 41, Subject Index

6

7

INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME

INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME 1 University of Papua New Guinea School of Medicine and Health Sciences Division of Basic Medical Sciences Discipline of Biochemistry and Molecular Biology PBL SEMINAR INSULIN RESISTANCE, POLYCYSTIC OVARIAN

More information

HEALTH UPDATE. Polycystic Ovary Syndrome (PCOS)

HEALTH UPDATE. Polycystic Ovary Syndrome (PCOS) HEALTH UPDATE PO Box 800760 Charlottesville, VA 22908 Gynecology: (434) 924-2773 Polycystic Ovary Syndrome (PCOS) What is it? An endocrine (hormonal) disorder. Because there is such variability in how

More information

Strategies and the Nursing Care Management of Adolescents Diagnosed with PCOS. Conflicts of Interest. Objectives. None Phaedra Thomas 4/23/2015

Strategies and the Nursing Care Management of Adolescents Diagnosed with PCOS. Conflicts of Interest. Objectives. None Phaedra Thomas 4/23/2015 Strategies and the Nursing Care Management of Adolescents Diagnosed with PCOS Phaedra Thomas, RN BSN Co-Director and Nurse Educator Center for Young Women s Health Boston Children s Hospital youngwomenshealth.org

More information

Polycystic Ovary Syndrome: Diagnosis and Treatment

Polycystic Ovary Syndrome: Diagnosis and Treatment The American Journal of Medicine (2007) 120, 128-132 UPDATE IN OFFICE MANAGEMENT Polycystic Ovary Syndrome: Diagnosis and Treatment Tracy L. Setji, MD, Ann J. Brown, MD, MHS Department of Medicine, Division

More information

POLYCYSTIC OVARY SYNDROME

POLYCYSTIC OVARY SYNDROME POLYCYSTIC OVARY SYNDROME Information Leaflet Your Health. Our Priority. Page 2 of 6 What is polycystic ovary syndrome? (PCOS) Polycystic ovary syndrome (PCOS) is the most common hormonal disorder in women

More information

Cardiovascular Disease Risk Factors Part XII Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005

Cardiovascular Disease Risk Factors Part XII Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005 Cardiovascular Disease Risk Factors Part XII By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005 As we approach the end of our extended series on cardiovascular disease risk factors,

More information

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 The cardiometabolic risk syndrome is increasingly recognized

More information

Polycystic Ovary Syndrome

Polycystic Ovary Syndrome Polycystic Ovary Syndrome Polycystic ovary syndrome (PCOS) is a disorder that affects as many as 5 10% of women. PCOS has three key features: 1) high levels of hormones called androgens; 2) irregular menstrual

More information

The PCOS - Diabetes Connection

The PCOS - Diabetes Connection PCOS Awareness Symposium 2015 Philadelphia Saturday, April 18 th, 2015 The PCOS - Diabetes Connection Preventing Stroke, Kidney Disease, Liver Disease & Other Complications Katherine Sherif, MD Professor

More information

INFERTILITY/POLYCYSTIC OVARIAN SYNDROME. Ovulatory Dysfunction: Polycystic ovarian syndrome (PCOS)

INFERTILITY/POLYCYSTIC OVARIAN SYNDROME. Ovulatory Dysfunction: Polycystic ovarian syndrome (PCOS) Introduction Infertility is defined as the absence of pregnancy following 12 months of unprotected intercourse. Infertility may be caused by Ovulatory Dysfunction, Blocked Fallopian Tubes, Male Factor

More information

Insulin Resistance and PCOS: A not uncommon reproductive disorder

Insulin Resistance and PCOS: A not uncommon reproductive disorder Insulin Resistance and PCOS: A not uncommon reproductive disorder Joyce L. Ross, MSN, CRNP, CS, FNLA, FPCNA Diplomate Accrediation Council for Clinical Lipidology President Preventive Cardiovascular Nurses

More information

FACT SHEET. The Polycystic Ovary Syndrome (PCOS) Introduction

FACT SHEET. The Polycystic Ovary Syndrome (PCOS) Introduction FACT SHEET The Polycystic Ovary Syndrome (PCOS) Introduction The polycystic ovary syndrome (PCOS) is the commonest hormonal disturbance to affect women. The main problems that women with PCOS experience

More information

Is Insulin Effecting Your Weight Loss and Your Health?

Is Insulin Effecting Your Weight Loss and Your Health? Is Insulin Effecting Your Weight Loss and Your Health? Teressa Alexander, M.D., FACOG Women s Healthcare Associates www.rushcopley.com/whca 630-978-6886 Obesity is Epidemic in the US 2/3rds of U.S. adults

More information

Evidence-based guideline for the assessment and management of polycystic ovary syndrome

Evidence-based guideline for the assessment and management of polycystic ovary syndrome Evidence-based guideline for the assessment and management of polycystic ovary syndrome Developed 2011 Updated August 2015 - Section 7.4 Aromatase inhibitors Further update scheduled 2016/2017 Publication

More information

DIABETES AND INSULIN RESISTANCE DIABETES PREVALANCE

DIABETES AND INSULIN RESISTANCE DIABETES PREVALANCE DIABETES AND INSULIN RESISTANCE KARI KOHRS RD LDN CDE UICMC NUTRITION & WELLNESS CENTER DIABETES PREVALANCE Third leading cause of death-- United States 18 million diagnosed Growing at the rate of 3 new

More information

Getting Off the Chronic Disease Merry-Go-Round: What s the Weight of the Research?

Getting Off the Chronic Disease Merry-Go-Round: What s the Weight of the Research? Getting Off the Chronic Disease Merry-Go-Round: What s the Weight of the Research? Jody Dushay, MD MMSc Beth Israel Deaconess Medical Center Boston, MA Session 445 No disclosures Disclosure Jody Dushay,

More information

Type 2 Diabetes Mellitus and Insulin resistance syndrome in Children

Type 2 Diabetes Mellitus and Insulin resistance syndrome in Children Type 2 Diabetes Mellitus and Insulin resistance syndrome in Children Anil R Kumar MD Pediatric Endocrinology MCV/VCU, Richmond VA Introduction Type 2 diabetes mellitus (T2 DM) has increased in children

More information

Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background. CAPA 2015 Annual Conference

Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background. CAPA 2015 Annual Conference Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group Learning Objectives To accurately make the diagnosis of pre-diabetes/metabolic syndrome To understand the prevalence

More information

Polycystic Ovarian Syndrome

Polycystic Ovarian Syndrome Polycystic Ovarian Syndrome What is Polycystic Ovarian Syndrome? Polycystic ovary syndrome (or PCOS) is a common condition affecting 3 to 5% of women of reproductive age. It is linked with hormonal imbalances,

More information

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen Version 1 2015 Module guide International Master Program Cardiovascular Science University of Göttingen Part 1 Theoretical modules Synopsis The Master program Cardiovascular Science contains four theoretical

More information

Diabetes and Obesity. The diabesity epidemic

Diabetes and Obesity. The diabesity epidemic Diabetes and Obesity Frank B. Diamond, Jr. M.D. Professor of Pediatrics University of South Florida College of Medicine The diabesity epidemic Prevalence of diabetes worldwide was over 135 million people

More information

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities Obesity Role of Body Weight Reduction in JMAJ 48(1): 47 1, 2 Hideaki BUJO Professor, Department of Genome Research and Clinical Application (M6) Graduate School of Medicine, Chiba University Abstract:

More information

Hirsutism and Polycystic Ovary Syndrome (PCOS)

Hirsutism and Polycystic Ovary Syndrome (PCOS) AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Hirsutism and Polycystic Ovary Syndrome (PCOS) A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under

More information

Type 2 Diabetes and Prediabetes: A New Understanding of Cause and Treatment. Bruce Latham, M.D. Endocrine Specialists Greenville Health System

Type 2 Diabetes and Prediabetes: A New Understanding of Cause and Treatment. Bruce Latham, M.D. Endocrine Specialists Greenville Health System Type 2 Diabetes and Prediabetes: A New Understanding of Cause and Treatment Bruce Latham, M.D. Endocrine Specialists Greenville Health System Objectives for this presentation - Understand the thrifty genotype

More information

From Menses to Menopause: How Hormones Can Affect Blood Glucose Levels. Christine Day, RN, MS, CNS-BC Lake Superior College

From Menses to Menopause: How Hormones Can Affect Blood Glucose Levels. Christine Day, RN, MS, CNS-BC Lake Superior College From Menses to Menopause: How Hormones Can Affect Blood Glucose Levels Christine Day, RN, MS, CNS-BC Lake Superior College Overview Will review hormonal changes over the female lifespan Discuss the effects

More information

DR. Trinh Thi Kim Hue

DR. Trinh Thi Kim Hue TYPE 2 DIABETES IN THE CHILD AND ADOLESCENT DR. Trinh Thi Kim Hue CONTENTS Definition Diagnosis Treatment Comorbidities and Complications Comorbidities and Complications Screening for T2D References DEFINITION

More information

Polycystic ovary syndrome (PCOS)

Polycystic ovary syndrome (PCOS) Centre for Diabetes and Endocrinology - Patient information Polycystic ovary syndrome (PCOS) Approximately 1 in 5 women have polycystic ovaries. This describes the appearance of the ovaries when they are

More information

PCOS. What to do about insulin resistance in. Aclearer understanding of. In this article: By R. Hugh Gorwill, MD, FRCSC

PCOS. What to do about insulin resistance in. Aclearer understanding of. In this article: By R. Hugh Gorwill, MD, FRCSC Focus on CME at Queen s University Queen s University What to do about insulin resistance in PCOS By R. Hugh Gorwill, MD, FRCSC In this article: Aclearer understanding of polycystic ovary syndrome (PCOS)

More information

Introduction. Pathogenesis of type 2 diabetes

Introduction. Pathogenesis of type 2 diabetes Introduction Type 2 diabetes mellitus (t2dm) is the most prevalent form of diabetes worldwide. It is characterised by high fasting and high postprandial blood glucose concentrations (hyperglycemia). Chronic

More information

Page 1 of 7 Polycystic Ovary Syndrome (PCOS), Insulin Resistance (IR), & the Metabolic Syndrome

Page 1 of 7 Polycystic Ovary Syndrome (PCOS), Insulin Resistance (IR), & the Metabolic Syndrome Page 1 of 7 Polycystic Ovary Syndrome (PCOS), Insulin Resistance (IR), & the Metabolic Syndrome I. LANE WONG, MD, FACOG. www.hopeivf.com www.hopefertilitycenter.com Polycystic Ovary Syndrome (PCOS), Insulin

More information

Polycystic Ovarian Syndrome (PCOS)

Polycystic Ovarian Syndrome (PCOS) UW MEDICINE PATIENT EDUCATION Polycystic Ovarian Syndrome (PCOS) Signs, symptoms, and treatments What is PCOS? Polycystic ovarian syndrome (PCOS) is a disorder that affects up to 1 in 10 women of reproductive

More information

WHAT DOES DYSMETABOLIC SYNDROME MEAN?

WHAT DOES DYSMETABOLIC SYNDROME MEAN? ! WHAT DOES DYSMETABOLIC SYNDROME MEAN? Dysmetabolic syndrome (also referred to as syndrome X, insulin resistance syndrome, and metabolic syndrome ) is a condition in which a group of risk factors for

More information

ACTIVITY DISCLAIMER. Polycystic Ovary Syndrome and Hyperandrogenism

ACTIVITY DISCLAIMER. Polycystic Ovary Syndrome and Hyperandrogenism Polycystic Ovary Syndrome and Hyperandrogenism Lisa G. Soldat, MD, MS, FAAFP ACTIVITY DISCLAIMER The material presented here is being made available by the American Academy of Family Physicians for educational

More information

POLYCYSTIC OVARY SYNDROME (PCOS), INSULIN RESISTANCE (IR), & METFORMIN: LATEST DEVELOPMENTS

POLYCYSTIC OVARY SYNDROME (PCOS), INSULIN RESISTANCE (IR), & METFORMIN: LATEST DEVELOPMENTS POLYCYSTIC OVARY SYNDROME (PCOS), INSULIN RESISTANCE (IR), & METFORMIN: LATEST DEVELOPMENTS I. Lane Wong, M.D., F.A.C.O.G. Board Certified, Reproductive Endocrinology and Infertility Recently, there has

More information

1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME

1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME 1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME Izet Aganović, Tina Dušek Department of Internal Medicine, Division of Endocrinology, University Hospital Center Zagreb, Croatia 1 Introduction The metabolic syndrome

More information

The Diabetes Epidemic

The Diabetes Epidemic The Diabetes Epidemic O 2118 Wilshire Blvd. Ste. 723 O Santa Monica, California 90403 O www.susandopart.com O susan@susandopart.com What to look for and how you can help your clients O 310-828-4476 Trends

More information

Diabetes mellitus. Lecture Outline

Diabetes mellitus. Lecture Outline Diabetes mellitus Lecture Outline I. Diagnosis II. Epidemiology III. Causes of diabetes IV. Health Problems and Diabetes V. Treating Diabetes VI. Physical activity and diabetes 1 Diabetes Disorder characterized

More information

Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline

Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline SPECIAL FEATURE Clinical Practice Guideline Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline Richard S. Legro, Silva A. Arslanian, David A. Ehrmann,

More information

Sex Hormones In Females And Related Disorders

Sex Hormones In Females And Related Disorders Sex Hormones In Females And Related Disorders (see previous newsletter article for males) Sex Hormone production and measurement in females Follicle Stimulating Hormone () Luteinizing Hormone (), Oestradiol

More information

CASE B1. Newly Diagnosed T2DM in Patient with Prior MI

CASE B1. Newly Diagnosed T2DM in Patient with Prior MI Newly Diagnosed T2DM in Patient with Prior MI 1 Our case involves a gentleman with acute myocardial infarction who is newly discovered to have type 2 diabetes. 2 One question is whether anti-hyperglycemic

More information

Body Composition & Longevity. Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ

Body Composition & Longevity. Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ Body Composition & Longevity Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ LONGEVITY Genetic 25% Environmental Lifestyle Stress 75% BMI >30 OBESE 25-30 OVERWEIGHT 18-25 NORMAL WEIGHT 18

More information

Hirsutism PCO Dr.Abdellatif Daraghmeh

Hirsutism PCO Dr.Abdellatif Daraghmeh Hormonal disorders in adolescent girls Hirsutism PCO Dr.Abdellatif Daraghmeh Objectives 1 provide understanding of endocrine disorders most spesificly the hirsutism and PCO in young female 2 - The importance

More information

Continuity Clinic Educational Didactic. December 8 th December 12 th

Continuity Clinic Educational Didactic. December 8 th December 12 th Continuity Clinic Educational Didactic December 8 th December 12 th MKSAP Question 1 A 60-year-old man is evaluated for a 1-year history of generalized fatigue and lack of energy. He has had erectile dysfunction

More information

Central Florida Research Update

Central Florida Research Update Central Florida Research Update Ayala, Julio, PhD, Sanford-Burnham Medical Research Institute, Orlando, Florida Anorectic Mechanisms of Glp1r Agonists Obesity Jan 1, 2014 Dec 31, 2018 Integrated Physiology,

More information

Master of Science. Obesity and Weight Management

Master of Science. Obesity and Weight Management Department of Clinical Sciences and Nutrition Master of Science in Obesity and Weight Management Dublin Part-Time Taught Modular Masters Programme Module Descriptor Outlines XN7201 The Obesity Epidemic

More information

Fertility. Impact of Insulin Resistance

Fertility. Impact of Insulin Resistance Fertility Impact of Insulin Resistance By: Fiona McCulloch BSc, ND White Lotus Naturopathic Clinic and Integrated Health 18 Greenfield Ave., Suite #201 Toronto, ON. M2N 3C8 www.whitelotusclinic.ca Part

More information

TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU

TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU Objectives: 1. To discuss epidemiology and presentation

More information

Diagnosis and treatment of polycystic ovary syndrome (PCOS): An interview with Richard Legro

Diagnosis and treatment of polycystic ovary syndrome (PCOS): An interview with Richard Legro Legro BMC Medicine (2015) 13:64 DOI 10.1186/s12916-015-0299-2 QUESTION AND ANSWER Diagnosis and treatment of polycystic ovary syndrome (PCOS): An interview with Richard Legro Richard Legro Open Access

More information

Hormones & Hormone Antagonists Chapter 40 - Katzung

Hormones & Hormone Antagonists Chapter 40 - Katzung Hormones & Hormone Antagonists hapter 40 - Katzung Least toxic of anticancer drugs Highly selective Breast, endometrial, prostate cancers 5 ategories Androgens Progestins Antiandrogens Gonadotropin-releasing

More information

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

More information

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering

More information

Weight Loss Surgery and Bariatric Nutrition. Jeanine Giordano, MS, RD, CDN

Weight Loss Surgery and Bariatric Nutrition. Jeanine Giordano, MS, RD, CDN Weight Loss urgery and Bariatric Nutrition Jeanine Giordano, M, RD, CDN UA: Mean BMI trends (age standardized) Prevalence of Obesity Among Adults United tates 68% Australia 59% Russia 54% United Kingdom

More information

Differential Diagnosis of NAFLD- A Short Summary:

Differential Diagnosis of NAFLD- A Short Summary: Differential Diagnosis of NAFLD- A Short Summary: Almost a fifth of our general pediatric population is now classified as overweight in the United States. When such children present with elevated liver

More information

4/11/14. Medical Director, Bariatric Surgery Mountainview Regional Medical Center. ! None. ! Discuss the ongoing epidemic of obesity

4/11/14. Medical Director, Bariatric Surgery Mountainview Regional Medical Center. ! None. ! Discuss the ongoing epidemic of obesity Medical Director, Bariatric Surgery Mountainview Regional Medical Center! None! Discuss the ongoing epidemic of obesity! Discuss current treatment options! Discuss the role of bariatric surgery! Review

More information

Vascular Risk Reduction: Addressing Vascular Risk

Vascular Risk Reduction: Addressing Vascular Risk Vascular Risk Reduction: Addressing Vascular Risk Vascular Risk Reduction (VRR) Welcome! Presentation & Activities Focus: Managing known risk factors for vascular disease. Engage, collaborate and have

More information

DIABETES YOUR GUIDE TO

DIABETES YOUR GUIDE TO YOUR GUIDE TO DIABETES b What is diabetes? b Type 2 diabetes prevention b Prevention checklist b Living with diabetes b Complications b Terms to know b Resources To promote and protect the health of Canadians

More information

Freiburg Study. The other 24 subjects had healthy markers closer to what would be considered ideal.

Freiburg Study. The other 24 subjects had healthy markers closer to what would be considered ideal. Freiburg Study The Freiburg Study was conducted with 48 healthy human subjects of various ages. None of the test subjects had been diagnosed with any disease prior to the study. None were taking any type

More information

PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY. 12a. FOCUS ON Your Risk for Diabetes. Copyright 2011 Pearson Education, Inc.

PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY. 12a. FOCUS ON Your Risk for Diabetes. Copyright 2011 Pearson Education, Inc. PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY 12a FOCUS ON Your Risk for Diabetes Your Risk for Diabetes! Since 1980,Diabetes has increased by 50 %. Diabetes has increased by 70 percent

More information

Obesity and the Menopause. Vanessa M. Barnabei, MD, PhD Professor and Chair Department of Obstetrics and Gynecology

Obesity and the Menopause. Vanessa M. Barnabei, MD, PhD Professor and Chair Department of Obstetrics and Gynecology Obesity and the Menopause Vanessa M. Barnabei, MD, PhD Professor and Chair Department of Obstetrics and Gynecology Educational Objectives Review normal menopausal transition Review health risks of obesity

More information

4/4/2013. Mike Rizo, Pharm D, MBA, ABAAHP THE PHARMACIST OF THE FUTURE? METABOLIC SYNDROME AN INTEGRATIVE APPROACH

4/4/2013. Mike Rizo, Pharm D, MBA, ABAAHP THE PHARMACIST OF THE FUTURE? METABOLIC SYNDROME AN INTEGRATIVE APPROACH METABOLIC SYNDROME AN INTEGRATIVE APPROACH AN OPPORTUNITY FOR PHARMACISTS TO MAKE A DIFFERENCE Mike Rizo, Pharm D, MBA, ABAAHP THE EVOLUTION OF THE PHARMACIST 1920s 1960s 2000s THE PHARMACIST OF THE FUTURE?

More information

Page 1 of 7 Polycystic Ovary Syndrome (PCOS), Insulin Resistance (IR), & the Metabolic Syndrome

Page 1 of 7 Polycystic Ovary Syndrome (PCOS), Insulin Resistance (IR), & the Metabolic Syndrome Page 1 of 7 Polycystic Ovary Syndrome (PCOS), Insulin Resistance (IR), & the Metabolic Syndrome I. LANE WONG, MD, FACOG. www.hopeivf.com Polycystic Ovary Syndrome (PCOS), Insulin Resistance (IR), Type

More information

trends in the treatment of Diabetes type 2 - New classes of antidiabetic drugs. IAIM, 2015; 2(4): 223-

trends in the treatment of Diabetes type 2 - New classes of antidiabetic drugs. IAIM, 2015; 2(4): 223- Review Article Pharmacological trends in the treatment of Diabetes type 2 - New classes of antidiabetic Silvia Mihailova 1*, Antoaneta Tsvetkova 1, Anna Todorova 2 1 Assistant Pharmacist, Education and

More information

Section 2. Overview of Obesity, Weight Loss, and Bariatric Surgery

Section 2. Overview of Obesity, Weight Loss, and Bariatric Surgery Section 2 Overview of Obesity, Weight Loss, and Bariatric Surgery What is Weight Loss? How does surgery help with weight loss? Short term versus long term weight loss? Conditions Improved with Weight Loss

More information

Diagnosis, classification and prevention of diabetes

Diagnosis, classification and prevention of diabetes Diagnosis, classification and prevention of diabetes Section 1 1 of 4 Curriculum Module II 1 Diagnosis, classification and presentation of diabetes Slide 2 of 48 Polyurea Definition of diabetes Slide 3

More information

PEDIATRIC OBESITY AND INSULIN RESISTANCE: Chronic Disease Risk and Implications for Treatment and Prevention Beyond Body Weight Modification

PEDIATRIC OBESITY AND INSULIN RESISTANCE: Chronic Disease Risk and Implications for Treatment and Prevention Beyond Body Weight Modification Annu. Rev. Nutr. 2005. 25:435 68 doi: 10.1146/annurev.nutr.25.050304.092625 Copyright c 2005 by Annual Reviews. All rights reserved First published online as a Review in Advance on April 15, 2005 PEDIATRIC

More information

Preconception Clinical Care for Women Medical Conditions

Preconception Clinical Care for Women Medical Conditions Preconception Clinical Care for Women All women of reproductive age are candidates for preconception care; however, preconception care must be tailored to meet the needs of the individual. Given that preconception

More information

IQ4I Research & Consultancy Pvt. Ltd. Type II Diabetes Mellitus Pipeline Analysis

IQ4I Research & Consultancy Pvt. Ltd. Type II Diabetes Mellitus Pipeline Analysis IQ4I Research & Consultancy Pvt. Ltd. Type II Diabetes Mellitus Pipeline Analysis CONTENTS REPORT DESCRIPTION INTRODUCTION Causes & Symptoms Diagnosis Unmet needs Epidemiology Current therapies HOT TARGETS,

More information

3/25/11. Finding Ways Around High Dose Insulin Requirements: U-500 Insulin, Weight Loss, and Future Therapies. Outline of Talk.

3/25/11. Finding Ways Around High Dose Insulin Requirements: U-500 Insulin, Weight Loss, and Future Therapies. Outline of Talk. Finding Ways Around High Dose Insulin Requirements: U-500 Insulin, Weight Loss, and Future Therapies Elaine K. Cochran, MSN, CRNP, BC-ADM National Institute of Diabetes and Digestive and Kidney Diseases

More information

The ABC s and T s of Male Infertility

The ABC s and T s of Male Infertility The ABC s and T s of Male Infertility Men s Health Initiative of BC - Focus on Testosterone Ethan D. Grober, MD, MEd, FRCSC Assistant Professor University of Toronto Department of Surgery, Division of

More information

Guidelines for Ordering Serum Levels of Gonadotropins (FSH, LH) and Prolactin CLP 021 Revised June, 2008 (Replaces October 2000 version)

Guidelines for Ordering Serum Levels of Gonadotropins (FSH, LH) and Prolactin CLP 021 Revised June, 2008 (Replaces October 2000 version) Guidelines for Ordering Serum Levels of Gonadotropins (FSH, LH) and Prolactin CLP 021 Revised June, 2008 (Replaces October 2000 version) 1. Scope This laboratory Guideline is intended to assist community

More information

GP tool. Polycystic ovary syndrome

GP tool. Polycystic ovary syndrome Polycystic ovary syndrome GP tool This resource is informed by the evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS), authored by the PCOS Australian Alliance

More information

The University of Hong Kong Department of Surgery Division of Esophageal and Upper Gastrointestinal Surgery

The University of Hong Kong Department of Surgery Division of Esophageal and Upper Gastrointestinal Surgery Program Overview The University of Hong Kong Department of Surgery Division of Esophageal and Upper Gastrointestinal Surgery Weight Control and Metabolic Surgery Program The Weight Control and Metabolic

More information

Cardiovascular Risk Reduction in Insulin Resistant. States. Thozhukat Sathyapalan M.B.B.S. MRCP Department of Medicine The University of Hull

Cardiovascular Risk Reduction in Insulin Resistant. States. Thozhukat Sathyapalan M.B.B.S. MRCP Department of Medicine The University of Hull Cardiovascular Risk Reduction in Insulin Resistant States Thozhukat Sathyapalan M.B.B.S. MRCP Department of Medicine The University of Hull A Thesis Submitted for the Degree of Doctor of Medicine to the

More information

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process

More information

Hyperandrogenic Disorders Task Force. Chairman. Neil F. Goodman, MD, FACE. Committee Members

Hyperandrogenic Disorders Task Force. Chairman. Neil F. Goodman, MD, FACE. Committee Members AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND TREATMENT OF HYPERANDROGENIC DISORDERS Hyperandrogenic Disorders Task Force Chairman Neil

More information

Men Sexual Dysfunction Associated with Obesity and Metabolic Syndrome

Men Sexual Dysfunction Associated with Obesity and Metabolic Syndrome Men Sexual Dysfunction Associated with Obesity and Metabolic Syndrome By Aly A. Abbassy, MD, FACE Professor of Medicine (Endocrinology) Alexandria University My Talk will include: 1-Types of Men sexual

More information

MORTALITY RISK FACTORS IN PATIENTS UNDERGOING GASTRIC BYPASS SURGERY

MORTALITY RISK FACTORS IN PATIENTS UNDERGOING GASTRIC BYPASS SURGERY Where Do We Stand? Alan M. Brader, MD Lancaster General Bariatrics Introduction The management of a patient with extreme obesity is a challenging task for most health care givers. Unfortunately, there

More information

Abdulaziz Al-Subaie. Anfal Al-Shalwi

Abdulaziz Al-Subaie. Anfal Al-Shalwi Abdulaziz Al-Subaie Anfal Al-Shalwi Introduction what is diabetes mellitus? A chronic metabolic disorder characterized by high blood glucose level caused by insulin deficiency and sometimes accompanied

More information

DIABETES MELLITUS GUIDELINES

DIABETES MELLITUS GUIDELINES DIABETES MELLITUS GUIDELINES Virginia Premier Health Plan Virginia Premier Health Plan, Clinical Practice Guideline-Diabetes 1. Population screening a. Indications i. Adults of any age with body mass index

More information

Diabetes and Heart Disease

Diabetes and Heart Disease Diabetes and Heart Disease Diabetes and Heart Disease According to the American Heart Association, diabetes is one of the six major risk factors of cardiovascular disease. Affecting more than 7% of the

More information

Nutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT

Nutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT 1 Nutrition Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT 2 Type 2 Diabetes: A Growing Challenge in the Healthcare Setting Introduction and background of type 2 diabetes:

More information

Overvekt, mer enn bare overvekt

Overvekt, mer enn bare overvekt Overvekt, mer enn bare overvekt Kurs Overvekt i svangerskap og fødsel Overvekt/fedme i historisk perspektiv I løpet av1-2 generasjoner har det vært en økning i forekomsten av fedme som er historisk uovertroffen.

More information

Adult Weight Management Training Summary

Adult Weight Management Training Summary Adult Weight Management Training Summary The Commission on Dietetic Registration, the credentialing agency for the Academy of Nutrition and Dietetics Marilyn Holmes, MS, RDN, LDN About This Presentation

More information

Jahnavi Srinivasan, MD Assistant Professor of General Surgery Emory University

Jahnavi Srinivasan, MD Assistant Professor of General Surgery Emory University Jahnavi Srinivasan, MD Assistant Professor of General Surgery Emory University Definition & Demographics The branch of medicine dealing with the diagnosis and treatment of obesity. BMI NIH Classification

More information

Strengthening the Pharmacist Skills in Managing Diabetes Practice Based Program 27 Contact Hours

Strengthening the Pharmacist Skills in Managing Diabetes Practice Based Program 27 Contact Hours Strengthening the Pharmacist Skills in Managing Diabetes Practice Based Program 27 Contact Hours Presented by New York State Council of Health system Pharmacists October 18 19, 2013 St. John s University,

More information

regulation of ECF composition and volume regulation of metabolism thyroid hormones, epinephrine, growth hormone, insulin and glucagon

regulation of ECF composition and volume regulation of metabolism thyroid hormones, epinephrine, growth hormone, insulin and glucagon Hormonal Effects regulation of ECF composition and volume ADH, aldosterone, ANF regulation of metabolism thyroid hormones, epinephrine, growth hormone, insulin and glucagon regulation of muscle contraction

More information

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine January 27, 2009 Dear Professors (representative) of departments, Subject:

More information

Medications for Inducing Ovulation

Medications for Inducing Ovulation AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Medications for Inducing Ovulation A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction

More information

MENOPAUSE WOMAN'S TEST (Assessment of hormone balance)

MENOPAUSE WOMAN'S TEST (Assessment of hormone balance) ATTACHMENT: Useful remarks for patient and doctor, to be associated to the analytical results. Your doctor should interpret this report. Cod. ID: 123456 CCV: 6bf Date: 01/01/2013 Patient: Rossi Mario Rapport

More information

Abigail R. Proffer, M.D. October 4, 2013

Abigail R. Proffer, M.D. October 4, 2013 Abigail R. Proffer, M.D. October 4, 2013 Topics Human Papillomavirus (HPV) Vaccines Pap smears Colposcopy Contraception Polycystic Ovary Syndrome (PCOS) Can I get pregnant? Miscarriage Abnormal Uterine

More information

ESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease

ESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease Diabetes, prediabetes and cardiovascular disease Classes of recommendations Levels of evidence Recommended treatment targets for patients with diabetes and CAD Definition, classification and screening

More information

Lifestyle and pharmacological interventions for the management of cardiovascular disease: dilemmas and perspectives

Lifestyle and pharmacological interventions for the management of cardiovascular disease: dilemmas and perspectives 7 t h Summer School of the Hellenic Atherosclerosis Society Lifestyle and pharmacological interventions for the management of cardiovascular disease: dilemmas and perspectives June 26 28, 2014, Crowne

More information

Medications for Inducing Ovulation

Medications for Inducing Ovulation AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Medications for Inducing Ovulation A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction

More information

Center for Healthy Weight and Nutrition. Adolescent Criteria for Bariatric Surgery

Center for Healthy Weight and Nutrition. Adolescent Criteria for Bariatric Surgery Center for Healthy Weight and Nutrition Adolescent Criteria for Bariatric Surgery When your patient needs specialized care, everything matters. A national leader in prevention and treatment, the Center

More information

ETIOLOGIC CLASSIFICATION. Type I diabetes Type II diabetes

ETIOLOGIC CLASSIFICATION. Type I diabetes Type II diabetes DIABETES MELLITUS DEFINITION It is a common, chronic, metabolic syndrome characterized by hyperglycemia as a cardinal biochemical feature. Resulting from absolute lack of insulin. Abnormal metabolism of

More information

EXPLORING THE INTERACTION BETWEEN EXERCISE AND MEDICATION FOR CHRONIC DISEASE: CONSIDERATIONS FOR FITNESS PROFESSIONALS

EXPLORING THE INTERACTION BETWEEN EXERCISE AND MEDICATION FOR CHRONIC DISEASE: CONSIDERATIONS FOR FITNESS PROFESSIONALS EXPLORING THE INTERACTION BETWEEN EXERCISE AND MEDICATION FOR CHRONIC DISEASE: CONSIDERATIONS FOR FITNESS PROFESSIONALS Steven T. Johnson, PhD 1 Introduction The prevalence of chronic diseases like cardiovascular

More information

Male Health. The three major issues are: Cardiovascular Health Prostate Health Fertility & Sexual Performance

Male Health. The three major issues are: Cardiovascular Health Prostate Health Fertility & Sexual Performance Male Health Do Men Value Their Health? The ancient Greek physician Hippocrates once said, A wise man ought to realise that his health is his most valuable possession. It is believed that Hippocrates lived

More information

Roux-en-Y Gastric Bypass

Roux-en-Y Gastric Bypass Roux-en-Y Gastric Bypass Restrictive and malabsorptive procedure Most frequently performed bariatric procedure in the US First done in 1967 Laparoscopic since 1993 75% EWL in 18-24 months 50% EWL is still

More information

FREQUENTLY ASKED QUESTIONS

FREQUENTLY ASKED QUESTIONS FREQUENTLY ASKED QUESTIONS Prime Surgicare Morbid Obesity and Treatment Options Qualifying for Bariatric Surgery Co-morbid Conditions Coping with Concerns Life After Surgery Morbid Obesity and Treatment

More information

Testosterone Replacement Therapy. Craig Ensign, MPAS, PA-C University of Utah School of Medicine Urology Division

Testosterone Replacement Therapy. Craig Ensign, MPAS, PA-C University of Utah School of Medicine Urology Division Testosterone Replacement Therapy Craig Ensign, MPAS, PA-C University of Utah School of Medicine Urology Division Lecture Outline 1. Anatomy and physiology 2. Definition and etiology 3. Signs and symptoms

More information